PN
The Pennant Group, Inc.
PNTG · NASDAQ
$42.48 +6.04% (+$2.42)
1M +2.02%
Market Cap $1.39B
P/E Ratio 43.00x
Div. Yield -
ROE 9.51%
Bulios Fair Price
$30.66
27.8% downside
Current Price
$42.48
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PNTG is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
22 /100
Expensive P/E 43.00x
EV/EBITDA 28.61x
PEG 1.51x
Growth
100 /100
Growing EPS growth 56.30%
Rev. growth 26.05%
Book val. growth 40.08%
Profitability
22 /100
Weak Gross margin 14.79%
Net margin 2.93%
FCF margin 2.36%
Quality
41 /100
Average ROIC 5.03%
ROE 9.51%
Asset turnover 1.06x
Debt
39 /100
Moderate Debt/Equity 1.38x
Current ratio 1.20x
Net debt/EBITDA 7.33x
Stability
70 /100
Stable Beta 1.27x
Rev. volatility 10.64%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PNTG
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Brent J. Guerisoli
Employees
9,700
Headquarters
Eagle
Upcoming events
04 NOV
Earnings
Upcoming earnings report